hypertrophic masseter
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18-40 years old; (2) Patients with benign masseter hypertrophy and broad lower 1/3 facial contour are indicated for botulinum toxin injection; 3. Never received botulinum toxin injection; 4. Do not receive any facial surgery, injection, photoelectric treatment, etc. within 6 months before treatment and during the study period; 5. Informed consent was obtained from all patients, who voluntarily accepted minimally invasive injection treatment, and authorized the use of their photos and ultrasound data.
Exclusion criteria
Exclusion criteria: 1. Diseases of the blood system, nervous system and immune system; 2. Coagulation dysfunction; 3. History of mental illness; 4. Long-term medication history; 5. For pregnant and lactating women, prepare a pregnancy plan within six months of the injection; 6. Communication disorders; 7. Poor cooperation and corresponding surgical contraindications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Length, width and thickness of masseter muscle at its highest point;Elastic parameters of masseter muscle;Echo intensity under ultrasound of masseter muscle; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction with appearance/contour;Physician satisfaction with treatment effectiveness;Sonographers scored the structural changes in the masseter muscle; | — |
Countries
China
Contacts
Plastic Surgery Hospital, Chinese Academy of Medical Sciences